20:25:09 EDT Tue 31 Mar 2026
Enter Symbol
or Name
USA
CA



Bausch Health Companies Inc
Symbol BHC
Shares Issued 372,578,315
Close 2026-03-31 C$ 7.52
Market Cap C$ 2,801,788,929
Recent Sedar+ Documents

Bausch Health to release Q1 2026 results April 29

2026-03-31 16:30 ET - News Release

Mr. Garen Sarafian reports

BAUSCH HEALTH TO ANNOUNCE FIRST QUARTER 2026 RESULTS ON APRIL 29, 2026

Bausch Health Companies Inc. will release first quarter 2026 financial results after market close on Wednesday, April 29, 2026. Bausch Health will host a live conference call and webcast at 5 p.m. ET to discuss results and provide a business update. All materials will be made available on the investor relations section of the Bausch Health website prior to the start of the call.

Conference call details

Date:  Wednesday, April 29, 2026

Time:  5 p.m. ET

Webcast:  Bausch Health website

A replay of the conference call will be available on the investor relations website.

About Bausch Health Companies Inc.

Bausch Health is a global diversified pharmaceutical company enriching lives through the company's relentless drive to deliver better health care outcomes. The company develops, manufactures and markets a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through the company's controlling interest in Bausch + Lomb. The company's ambition is to be a globally integrated health care company, trusted and valued by patients, HCPs, employees and investors.

© 2026 Canjex Publishing Ltd. All rights reserved.